Background: Studies comparing data between the high-power short-duration radiofrequency (HPSR) and low power longer duration therapy were limited and inconsistent. Therefore, we conduct a high-quality systematic review and meta-analysis to assess the efficacy and safety of HPSR on outcomes for patients with atrial fibrillation (AF).
Methods: The online literature is searched using the following combination of medical subject heading terms: "high-power" OR "high power" AND "radiofrequency" AND "atrial fibrillation." MEDLINE (PubMed), EMBASE (OVID), Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science (ISI database) will be searched without any language restrictions. All clinical trials to assess the efficacy and safety of HPSR in the treatment of atrial fibrillation will be considered eligible for analysis. The present study will be performed by Review Manager Software (RevMan Version 5.3, The Cochrane Collaboration, Copenhagen, Denmark). Ethical approval and patient consent are not required because this study is a literature-based study.
Results: This study expects to provide credible and scientific evidence for the efficacy and safety of HPSR on outcomes for patients with AF.
Registration number: 10.17605/OSF.IO/WAEBN.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.